Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective National Post-marketing Surveillance for the Investigation of the Efficacy and Safety of SpaceOAR™ to Maintain Space Between the Rectum and Prostate During Radiation Therapy

NCT01999660 is registered in ClinicalTrials.gov with CS Diagnostics GmbH as lead sponsor.

NCT NCT01999660
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01999660 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective National Post-marketing Surveillance for the Investigation of the Efficacy and Safety of SpaceOAR™ to Maintain Space Between the Rectum and Prostate During Radiation Therapy
Lead sponsor
CS Diagnostics GmbH
Phase
Observational
Overall status
Terminated
Start date
November 30, 2013
Completion date
August 31, 2019
Enrollment
119 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer patients treated by radiotherapy